Fmoc-D-allo-isoleucine

Fmoc-D-allo-isoleucine is an Fmoc-protected D-configured allo-isoleucine amino acid building block in which the stereogenic center at the α-carbon is set to the D-allo arrangement and the α-amino functionality is masked as a fluorenylmethoxycarbonyl (Fmoc) carbamate. The side chain presents a branched aliphatic framework with stereochemical differentiation relative to standard isoleucine, enabling distinct conformational preferences in peptide chains and peptidomimetics. The molecule bears a protected amine for controlled peptide coupling and a carboxylic acid that can be engaged as an activated acid equivalent during synthesis, while its Fmoc group supports orthogonal protection strategies compatible with stepwise solid-phase or solution-phase assembly. The combination of a chiral amino acid core and a removable Fmoc protecting group makes Fmoc-D-allo-isoleucine a practical chiral intermediate for generating stereochemically defined peptide fragments and downstream derivatization targets.

1. Peptide Synthesis

Fmoc-D-allo-isoleucine supports peptide building block preparation for stepwise peptide coupling in both solid-phase peptide synthesis and solution-phase fragment assembly. The Fmoc carbamate protects the α-amine during iterative deprotection and coupling cycles, while the carboxylic acid functionality participates as an activated amino acid component to form amide bonds with controlled stereochemistry. The D-allo stereochemical identity can influence backbone and side-chain packing, which is relevant when assembling peptides that require defined diastereomeric outcomes or conformational tuning. The resulting D-allo-containing peptide sequences can be carried forward into peptide analog construction, structure-activity relationship studies, and synthetic standards for stereochemical verification in amino acid chemistry workflows.

2. Unnatural Amino Acid Incorporation

Fmoc-D-allo-isoleucine serves as a chiral unnatural amino acid intermediate for incorporating noncanonical stereochemistry into peptide scaffolds used in chemical biology and SAR investigations. The D-configuration at the α-carbon and the allo isomeric side-chain topology provide a stereochemically distinct residue compared with canonical L-isoleucine, enabling systematic evaluation of stereochemical effects on molecular recognition. The protected amine and reactive carboxyl group allow incorporation into peptide chains under standard peptide coupling conditions after Fmoc deprotection, supporting consistent manufacturing-like synthesis of defined analog libraries. Downstream peptide products can be used to probe sequence-dependent conformational behavior and to generate stereochemically defined fragments for peptidomimetic design.

3. Side-Chain Functionalization

Fmoc-D-allo-isoleucine can be employed as a chiral precursor for side-chain functionalization strategies that target branched aliphatic motifs for further chemical diversification. The protected α-amino group and the Fmoc handle enable controlled downstream transformations by separating peptide-ready functionality from side-chain modification steps, supporting orthogonal protection logic in multi-step syntheses. The stereogenic allo framework can be retained while converting the side chain into reactive intermediates for subsequent conjugation, labeling, or incorporation into functional materials precursors. Resulting derivatives may serve as intermediates for chemical manufacturing routes where stereochemical integrity and peptide compatibility are required for producing defined functionalized amino acid derivatives.

4. Peptidomimetics And SAR

Fmoc-D-allo-isoleucine is suitable for peptidomimetic construction where stereochemically defined amino acid residues modulate conformational constraints and binding-site interactions. The Fmoc-protected amino acid format facilitates assembly of short peptide segments or peptide-like fragments that can later be cyclized, truncated, or chemically remodeled while retaining the D-allo stereocenter as a structural determinant. The carboxyl-derived amide linkage formation supports generating consistent backbone connectivity, enabling comparative SAR studies across diastereomeric or stereochemically varied analog series. The resulting stereodefined fragments can be used to prepare molecular libraries and reference compounds for analytical characterization of structure-function relationships in peptide science.

5. Pharmaceutical Intermediate Preparation

Fmoc-D-allo-isoleucine can be applied in pharmaceutical intermediate preparation for manufacturing-oriented synthesis of defined chiral amino acid residues used in peptide-based research reagents and process development. The Fmoc protecting group provides a robust, removable protection strategy for handling the α-amino functionality during controlled synthetic sequences, which aligns with industrially relevant protection/deprotection planning. The chiral amino acid core supports reproducible formation of amide bonds in upstream intermediate generation, allowing downstream conversion into peptide fragments, protected intermediates, or conjugatable building blocks for specialty chemical production. The stereochemical specificity of the D-allo residue supports consistent intermediate identity for process chemistry intermediate preparation and analytical method development tied to stereochemical integrity in amino acid derivative manufacturing.

1. Effect of Short-Term Desiccation, Recovery Time, and CAPA-PVK Neuropeptide on the Immune System of the Burying Beetle Nicrophorus vespilloides

2. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors

3. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate

4. Myotropic activity of allatostatins in tenebrionid beetles

5. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review